About
TriVascular, Inc. is a medical device company based in Santa Rosa, California, founded in 1998. The company focuses on developing less-invasive endovascular therapies for treating abdominal aortic aneurysms (AAA). Its flagship product, the Ovation Endovascular Stent Graft System, was launched in 2010. This innovative device features a unique design that incorporates an injectable polymer, allowing for delivery through a narrower catheter. This advancement enables treatment for a wider range of patients, including those with challenging vascular anatomies. TriVascular's technology offers a significant improvement over traditional open surgery for AAA repair, which is more invasive and requires a large abdominal incision. The endovascular approach reduces recovery time and procedural risks for patients. The company is also working on thoracic aortic stent-grafts to expand its treatment options for vascular diseases. In 2015, TriVascular was acquired by Boston Scientific, which has supported the further development and commercialization of its technologies.
Technologies
Keywords
Company Information
- Employees43
- Founded1998
- Annual Revenue$35000000
- Total Funding$128000000
Location
3910 Brickway Boulevard, Santa Rosa, California, United States, 95403
